eNeura Therapeutics added to the $2.2 million it raised earlier this year with another $1.6 million deposit, part of a hoped-for $2 million funding round, according to a regulatory filing.
Sunnyvale, Calif.-based eNeura makes a transcranial magnetic stimulation device designed to treat migraine headaches.
Late last year eNeura won clearance from the FDA for the Cerena device via the watchdog agency’s de novo approval process. Earlier this year the company reported landing $2.2 million in an equity offering.
The most recent round attracted 15 unnamed investors in a debt-and-options offering, according to the filing.